Possible neuroendocrine phenotype of poorly differentiated cell clusters in colorectal carcinoma, as a prognostic parameter.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer.World journal of gastroenterology · 2016
   Pooled it
2. Mixed neuroendocrine-non-neuroendocrine neoplasm arising from long-segment Barrett's esophagus showing exceptionally aggressive clinical behavior.Cancer reports (Hoboken, N.J.) · 2022
   Article
3. Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe.Cancers · 2021
   Review
4. Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.World journal of gastroenterology · 2015
   Review
5. Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues Oncologues.Medicine · 2015
   Observational
6. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.World journal of gastroenterology · 2015
   Article
7. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.International journal of clinical and experimental pathology · 2014
   Article

Corrections and comments

• Comment on
  New criteria for histologic grading of colorectal cancer.2012
• Comment on
  Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.2012
• Comment on
  Colorectal carcinoma grading quantified by counting poorly differentiated clusters: is it feasible on endoscopic biopsies?2013

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as